| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,232,310 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,232,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-15 |
4 |
D |
$42.31 |
$34,863 |
D/D |
(824) |
263,171 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$6,156 |
D/D |
(833) |
76,288 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-21 |
4 |
D |
$42.62 |
$36,227 |
D/D |
(850) |
264,034 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-23 |
4 |
D |
$40.52 |
$36,954 |
D/D |
(912) |
253,999 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-23 |
4 |
D |
$42.62 |
$38,912 |
D/D |
(913) |
265,910 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-16 |
4 |
D |
$14.98 |
$13,871 |
D/D |
(926) |
113,645 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-16 |
4 |
D |
$7.54 |
$7,005 |
D/D |
(929) |
69,485 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-16 |
4 |
D |
$13.30 |
$12,356 |
D/D |
(929) |
81,718 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-22 |
4 |
D |
$40.52 |
$37,846 |
D/D |
(934) |
253,072 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-22 |
4 |
D |
$42.62 |
$39,807 |
D/D |
(934) |
264,983 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$16,720 |
D/D |
(1,006) |
127,032 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-24 |
4 |
D |
$17.33 |
$17,434 |
D/D |
(1,006) |
170,710 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-27 |
4 |
D |
$17.21 |
$18,294 |
D/D |
(1,063) |
172,036 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-24 |
4 |
D |
$27.20 |
$36,094 |
D/D |
(1,327) |
229,837 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-24 |
4 |
D |
$40.52 |
$53,770 |
D/D |
(1,327) |
255,348 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,629 |
255,277 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,629 |
267,539 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,629 |
245,625 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,630 |
177,822 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• – – |
2012-02-12 |
4 |
D |
$5.93 |
$9,802 |
D/D |
(1,653) |
51,984 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
263,995 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
241,057 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
173,067 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, Neuromodula |
• – – |
2011-10-31 |
4 |
D |
$5.81 |
$9,703 |
D/D |
(1,670) |
48,246 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2012-10-30 |
4 |
D |
$5.17 |
$8,686 |
D/D |
(1,680) |
65,272 |
0 |
- |
|
176 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
